BY DR. GSK VELU, FOUNDER AND MANAGING DIRECTOR, TRIVITRON GROUP OF COMPANIES:
New Delhi, Jan 03, 2015: “While 100% FDI in Medical Devices sector is a welcome in our opinion this was already in existence and many MNCs have 100% subsidiaries in India though predominantly with trading and distribution focus. As a part of this new initiative actions should be taken to control and restrict 100% trading subsidiary operations in India. These trading subsidiaries does not have any manufacturing intent and in fact even distribution margins are being expatriated back to their parent countries by adopting several means. Hence apart from 100% FDI in Medical Devices sector government should create right eco system for manufacturing in the country which presently has ” Pro Imports” policies with Inverse Duty structure, lack of control on imports using High Sea Sales route and no coordinated efforts between Academia/ Indian Industry in the R&D initiatives. While MNC s should be encouraged to come and manufacture in India, Indian Domestic companies with majority Indian Ownership should be given special preference in Govt Procurement etc as it is happening in other countries like China, Turkey, Brazil, Russia and many other countries. We sincerely hope a New Medical Devices wing will be created under Department of Pharmaceuticals to promote Indigenous Medical Devices companies by understanding and attending to their needs in this budget.
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…